FinTrust Capital Advisors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $43.4K | Hold |
121
| – | – | 0.01% | 608 |
|
2024
Q2 | $38.5K | Hold |
121
| – | – | 0.01% | 600 |
|
2024
Q1 | $27.8K | Hold |
121
| – | – | 0.01% | 661 |
|
2023
Q4 | $26.6K | Sell |
121
-2
| -2% | -$440 | 0.01% | 622 |
|
2023
Q3 | $27.8K | Buy |
123
+11
| +10% | +$2.49K | 0.01% | 590 |
|
2023
Q2 | $31.1K | Hold |
112
| – | – | 0.01% | 538 |
|
2023
Q1 | $31.1K | Hold |
112
| – | – | 0.01% | 538 |
|
2022
Q4 | $31.1K | Hold |
112
| – | – | 0.01% | 538 |
|
2022
Q3 | $25K | Buy |
112
+5
| +5% | +$1.12K | 0.01% | 673 |
|
2022
Q2 | $24K | Sell |
107
-8
| -7% | -$1.79K | 0.01% | 692 |
|
2022
Q1 | $20K | Sell |
115
-100
| -47% | -$17.4K | ﹤0.01% | 766 |
|
2021
Q4 | $46K | Hold |
215
| – | – | 0.01% | 566 |
|
2021
Q3 | $40K | Hold |
215
| – | – | 0.01% | 581 |
|
2021
Q2 | $39K | Hold |
215
| – | – | 0.01% | 591 |
|
2021
Q1 | $36K | Sell |
215
-34
| -14% | -$5.69K | 0.01% | 584 |
|
2020
Q4 | $38K | Sell |
249
-41
| -14% | -$6.26K | 0.01% | 534 |
|
2020
Q3 | $29 | Sell |
290
-134
| -32% | -$13 | 0.01% | 576 |
|
2020
Q2 | $51K | Buy |
+424
| New | +$51K | 0.02% | 481 |
|